A detailed history of Norges Bank transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Norges Bank holds 366,661 shares of TMDX stock, worth $26.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
366,661
Holding current value
$26.4 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$59.28 - $144.9 $21.7 Million - $53.1 Million
366,661 New
366,661 $22.9 Million
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $19.6 Million - $40.6 Million
269,874 New
269,874 $40.6 Million
Q1 2023

May 15, 2024

BUY
$53.63 - $82.33 $6.95 Million - $10.7 Million
129,500 New
129,500 $9.81 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.29B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.